Strata Critical Medical, Inc. (SRTA) News
Track canonical SquawkNews coverage tagged to SRTA, Strata Critical Medical, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 9 indexed stories across 5 publication days and is ordered by the same first-publication timeline used by LiveCast.
H
Strata Critical Medical Q2 2026 Earnings Call Transcript
Strata Critical Medical (NASDAQ: SRTA ) released second-quarter financial results and hosted an earnings call on Tuesday. Read the complete transcript below. This content is powered APIs. For comprehensive financial data
LIVE | Sep 28, 2026, 08:11 AM UTC
L
SRTA: Regulatory and tech shifts are fueling double-digit growth in organ transplant logistics and clinical services
The conference highlighted rapid growth in organ transplant logistics and clinical services, driven by regulatory and technological changes that increase donor-recipient distances and expand the donor pool. The business
NEWS | Sep 14, 2026, 07:52 PM UTC
L
SRTA: Rapid growth in transplant logistics and clinical services driven by innovation and acquisitions
Facing a fragmented and rapidly evolving transplant industry, the company leverages an asset-light, end-to-end logistics and clinical service model to address organ shortages and capitalize on regulatory and technologica
MNA | Sep 14, 2026, 07:19 PM UTC
L
Strata Critical to present at Jefferies healthcare services conference on Sept. 14
Strata Critical Medical will present at the 2026 Jefferies Healthcare Services and Technology Conference on Monday, September 14, 2026, at 2:15 pm ET, with a webcast available.
EQUITY | Sep 08, 2026, 09:07 PM UTC
L
Strata to present at Jefferies 2026 healthcare services conference
Strata said it will present at the 2026 Jefferies Healthcare Services and Technology Conference.
EQUITY | Sep 08, 2026, 09:05 PM UTC
L
SRTA - Strata Critical Medical Announces Second Quarter 2026 Results
SRTA - Strata Critical Medical Announces Second Quarter 2026 Results
EARNINGS | Aug 04, 2026, 12:51 PM UTC
L
Strata Critical Medical Raises FY2026 Sales Guidance from $260.000M-$275.000M to $285.000M-$295.000M vs $275.746M Est
Strata Critical Medical (NASDAQ: SRTA ) raises FY2026 sales outlook from $260.000 million-$275.000 million to $285.000 million-$295.000 million vs $275.746 million estimate.
EARNINGS | Aug 04, 2026, 11:01 AM UTC
M
SRTA Acquires Transplant Program
Strata Critical Medical acquires Heart And Lung Transplant National Recovery Program for $21.5M
EQUITY | Jun 24, 2026, 01:06 PM UTC
M
SRTA Acquires Transplant Program
Strata acquires Heart and Lung Transplant National Recovery Program, expanding national organ recovery platform
EQUITY | Jun 24, 2026, 01:00 PM UTC